|
CN105287456A
|
|
Composition and application thereof to medicines with functions of preventing and treating liver injury
|
|
CN105287454A
|
|
Composition and application thereof to anti-inflammatory medicines
|
|
CN105287465A
|
|
Composition and application thereof to antibacterial medicines
|
|
CN105287457A
|
|
Composition and application thereof to medicines with function of increasing leukocytes
|
|
CN105287458A
|
|
Composition and application thereof to antiviral medicines
|
|
CN105287466A
|
|
Composition and application thereof to hepatic fibrosis resistant medicines
|
|
CN105287462A
|
|
Composition and application thereof to anti-hypoxia medicines
|
|
CN105287459A
|
|
Composition and application thereof to heart failure resistant medicines
|
|
CN105287464A
|
|
Composition and application thereof to osteoporosis resistant medicines
|
|
CN105287455A
|
|
Composition and application thereof to medicines resistant to anemia due to low red cells
|
|
CN105287463A
|
|
Composition and application thereof to acute renal failure (ARF) resistant medicines
|
|
CN105287524A
|
|
Composition and application of composition to medicine for increasing white blood cells
|
|
CN105287527A
|
|
Composition and application of composition in anti-hepatic-fibrosis medicine
|
|
CN105287526A
|
|
Composition and application of composition to anti-inflammatory drugs
|
|
CN105287525A
|
|
Composition and application of composition in medicine for resisting low red blood cell type anemia
|
|
CN105287528A
|
|
Composition and application of composition in antibacterial drugs
|
|
CN105287549A
|
|
Composition and application of composition to anti-inflammatory drugs
|
|
CN105287565A
|
|
Composition and application thereof to chronic obstructive pulmonary disease (COPD) resistant medicines
|
|
CN105287569A
|
|
Composition and application thereof to medicines for preventing or treating pancreatic fibrosis
|
|
CN105287557A
|
|
Composition and application thereof to rhinitis resistant medicines
|
